(Q33732171)

29 July 2017

Depigmented-polymerised allergoids favour regulatory over effector T cells: enhancement by 1α, 25-dihydroxyvitamin D3. (English)

1 reference

29 July 2017

Jerónimo Carnés

5

0 references

Catherine M. Hawrylowicz

object named as

Catherine M Hawrylowicz

6

0 references

Maria Aurora Morales

4

object named as

Maria Morales

1 reference

29 July 2017

Zoe L Urry

1

1 reference

29 July 2017

David F Richards

2

1 reference

29 July 2017

Cheryl Black

3

1 reference

29 July 2017

Douglas S Robinson

7

1 reference

29 July 2017

29 May 2014

1 reference

29 July 2017

1 reference

29 July 2017

15

1 reference

29 July 2017

21

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2172-15-21

29 July 2017

0 references

cites work

The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051145

Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051145

Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3 abrogates regulatory function.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051145

Comparison of allergenicity and immunogenicity of an intact allergen vaccine and commercially available allergoid products for birch pollen immunotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051145

Successful management of mite-allergic asthma with modified extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae in a double-blind, placebo-controlled study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051145

Immunoglobulin E-independent major histocompatibility complex-restricted T cell peptide epitope-induced late asthmatic reactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051145

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051145

Safety of a depigmented, polymerized vaccine for the treatment of allergic rhinoconjunctivitis and allergic asthma

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2172-15-21

Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2172-15-21

Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2172-15-21

1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2172-15-21

Skin tests with native, depigmented and glutaraldehyde polymerized allergen extracts

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4051145

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2172-15-21

Serum 25-dihydroxyvitamin D levels correlate with CD4+Foxp3+ T-cell numbers in moderate/severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2172-15-21

Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

12 December 2020

Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis

1 reference

12 December 2020

Mechanisms of allergen-specific immunotherapy

1 reference

12 December 2020

Reactivity of T cells with grass pollen allergen extract and allergoid

1 reference

12 December 2020

T cell reactivity with allergoids: influence of the type of APC

1 reference

12 December 2020

Analysis of the CD4+ T cell responses to house dust mite allergoid

1 reference

12 December 2020

Modified forms of allergen immunotherapy

1 reference

12 December 2020

Responses of human birch pollen allergen-reactive T cells to chemically modified allergens (allergoids)

1 reference

12 December 2020

Standards for practical allergen-specific immunotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2172-15-21

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference